Camilla Kara Svensson

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder

Julie Rask Larsen, Louise Vedtofte, Mathilde S. L. Jakobsen et al. · JAMA Psychiatry · 2017 · 227 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

One‐year follow‐up on liraglutide treatment for prediabetes and overweight/obesity in clozapine‐ or olanzapine‐treated patients

Camilla Kara Svensson, Julie Rask Larsen, Louise Vedtofte et al. · Acta Psychiatrica Scandinavica · 2018 · 60 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up

Markus Lundgren, Åsa Sahlin, Camilla Kara Svensson et al. · Pediatric Diabetes · 2014 · 45 citations

Medicine, Child Health, Pediatrics +16

The significance of sampling time in therapeutic drug monitoring of clozapine

Michelle Iris Jakobsen, Julie Rask Larsen, Camilla Kara Svensson et al. · Acta Psychiatrica Scandinavica · 2016 · 30 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine

Julie Rask Larsen, Camilla Kara Svensson, Louise Vedtofte et al. · CNS Spectrums · 2018 · 30 citations

Medicine, Pharmacotherapy, Psychiatry +17